secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001932393-23-000007
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare Q4 revenue $4.9B, adj EPS $1.31; FY23 adj EPS guidance $3.60-$3.75
--------------------------------------------------------------------------------

- Q4 revenue $4.9B (+8% reported, +13% organic); net income $554M, EPS $1.21, adjusted EPS $1.31.
- FY22 revenue $18.3B (+4% reported, +7% organic); net income $1.9B, EPS $4.18, adjusted EPS $4.63.
- FY23 guidance: organic revenue growth 5-7%, adj EBIT margin 15.0-15.5%, adj EPS $3.60-$3.75, FCF conversion 85%+.
- Cash from operations $2.1B, free cash flow $1.8B for FY22; cash conversion 111%.
- Announced agreement to acquire IMACTIS to strengthen interventional guidance capabilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239323000007/0001932393-23-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239323000007/gehc-20230130.htm
  HTML page:      https://secwatch.observer/filing/0001932393-23-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer